Actor and entrepreneur Kunal Kapoor, along with Ketto co-founders Varun Sheth and Zaheer Adenwala, has launched MetaGO, a healthtech startup focused on obesity and metabolic health management.
The platform offers a doctor-led care model that integrates metabolic diagnostics, specialist consultations, nutrition counselling, lifestyle coaching and, where clinically appropriate, GLP-1 therapies for patients living with obesity and related metabolic disorders.
From Fundraising to Preventive Healthcare
The founders say the idea emerged from their experience building healthcare crowdfunding platform Ketto, where they frequently encountered patients seeking financial support after chronic conditions had already reached advanced stages.
“Fourteen years of building Ketto teaches you to see patterns. We met thousands of families at some of the hardest moments of their lives, often after years of diabetes, obesity, or other metabolic conditions had progressed. Over time, it became clear that many of those conditions had begun developing years before anyone needed medical treatment,” Kapoor said.
MetaGO aims to address that gap by shifting the focus toward earlier diagnosis and continuous clinical management rather than episodic treatment.
Every patient begins with a metabolic assessment covering more than 35 biomarkers. Based on the results, specialists including endocrinologists and cardiologists develop personalised treatment plans supported by nutrition guidance, fitness coaching and regular follow-ups.
GLP-1 Drugs Becoming Part of Broader Care Models
The launch comes as GLP-1 medications are reshaping obesity treatment globally. Originally developed for diabetes management, these therapies have demonstrated significant weight-loss benefits and are increasingly being prescribed under medical supervision for obesity. MetaGO, however, positions medication as one element of a wider clinical programme.
“GLP-1 therapies have genuinely changed what’s possible for many people living with obesity, but medication is only one part of the journey. Lasting outcomes come from combining it with medical supervision, nutrition, behaviour change and ongoing support,” Kapoor said.
India’s Digital Health Opportunity
India’s growing burden of lifestyle diseases is creating demand for digital health platforms that extend beyond virtual consultations to deliver continuous care. According to the International Diabetes Federation, India has one of the world’s largest populations living with diabetes, while obesity rates continue to rise across both urban and semi-urban regions.
This has opened opportunities for healthtech companies building technology-enabled care pathways that combine remote monitoring, digital consultations and personalised treatment plans for chronic disease management. The adoption of AI-driven analytics, connected health devices and longitudinal patient data is also enabling providers to track health indicators over time instead of relying solely on periodic clinical visits.
Building a Long-Term Care Platform
Beyond its digital platform, MetaGO has started community outreach initiatives, including metabolic health camps offering blood tests and physician consultations. The company says it plans to expand these programmes to reach additional professional groups and improve awareness around metabolic health.
As obesity increasingly becomes recognised as a chronic medical condition rather than simply a lifestyle issue, startups are exploring integrated care models that combine technology with specialist-led clinical services. MetaGO enters this market with a focus on long-term engagement, betting that preventive care and continuous monitoring will play a larger role in managing India’s growing metabolic health challenge.
